MedTrace Logo

Supportive and Supportive-Expressive Treatment for Depression

NCT02728557 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-01-27

Study results available
· View outcomes & findings →

Summary

This study will assign patients to two types of psychotherapies in treating people with a major depression disorder, expressive versus supportive techniques, and will examine their ability to benefit from treatment based on their attachment orientation. This is a four month protocol, with a year follow up period, will compare patients receiving supportive-expressive treatment with either expressive focus or supportive focus.

Conditions

Interventions

BEHAVIORAL

Supportive-Expressive Therapy

Supportive-expressive psychotherapy for depressive disorder for 16 weeks.

BEHAVIORAL

Supportive Therapy

Supportive psychotherapy for depressive disorder for 16 weeks.

Sponsors & Collaborators

  • University of Haifa

    lead OTHER

Principal Investigators

  • Sigal Zilcha Mano · University of Haifa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-02
Primary Completion
2021-02-17
Completion
2023-10-17

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02728557 on ClinicalTrials.gov